The Asia Pacific Krill Oil Market would witness market growth of 11.7% CAGR during the forecast period (2024-2031).
The China market dominated the Asia Pacific Krill Oil Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $154.2 million by 2031. The Japan market is registering a CAGR of 11% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 12.4% during (2024 - 2031).
Pharmaceutical companies are exploring the potential of combining oil with other pharmaceutical agents to enhance therapeutic outcomes. Combination therapies may include the oil supplements as adjunctive therapy for patients with cardiovascular disease, metabolic disorders, or inflammatory conditions. Scientific evidence and clinical research support pharmaceutical-grade krill supplements, giving healthcare professionals confidence in their efficacy and safety.
For instance, as per China.org, in 2021, the combined business revenue of China’s pharmaceutical companies increased by 18.7 percent annually, the greatest growth rate in five years. Clinical validation helps to establish krill as a credible and effective supplement for preventive and therapeutic use. Pharmaceutical-grade oil supplements may offer advantages in terms of purity, quality, and dosage consistency compared to over-the-counter supplements.
Senior citizens in China are becoming increasingly health-conscious and actively seeking products to help them maintain their health and quality of life as they age. Consumers in China, including senior citizens, are well-informed about the health benefits of omega-3 fatty acids. Omega-3 fatty acids in krill are known to support heart health by reducing inflammation, lowering triglyceride levels, and improving cholesterol profiles, making oil supplements an important part of cardiovascular health management for seniors in China. By 2045, the United Nations estimates that approximately 450 million individuals in China will be 60 or older. Therefore, due to the above-mentioned factors, the market will grow significantly in this region.
Based on Product Type, the market is segmented into Liquid, Softgels and Capsules. Based on Application, the market is segmented into Dietary Supplements, Animal Food & Pet Food, Functional Food & Beverages, Pharmaceuticals and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Australia, Malaysia, and Rest of Asia Pacific.
The China market dominated the Asia Pacific Krill Oil Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $154.2 million by 2031. The Japan market is registering a CAGR of 11% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 12.4% during (2024 - 2031).
Pharmaceutical companies are exploring the potential of combining oil with other pharmaceutical agents to enhance therapeutic outcomes. Combination therapies may include the oil supplements as adjunctive therapy for patients with cardiovascular disease, metabolic disorders, or inflammatory conditions. Scientific evidence and clinical research support pharmaceutical-grade krill supplements, giving healthcare professionals confidence in their efficacy and safety.
For instance, as per China.org, in 2021, the combined business revenue of China’s pharmaceutical companies increased by 18.7 percent annually, the greatest growth rate in five years. Clinical validation helps to establish krill as a credible and effective supplement for preventive and therapeutic use. Pharmaceutical-grade oil supplements may offer advantages in terms of purity, quality, and dosage consistency compared to over-the-counter supplements.
Senior citizens in China are becoming increasingly health-conscious and actively seeking products to help them maintain their health and quality of life as they age. Consumers in China, including senior citizens, are well-informed about the health benefits of omega-3 fatty acids. Omega-3 fatty acids in krill are known to support heart health by reducing inflammation, lowering triglyceride levels, and improving cholesterol profiles, making oil supplements an important part of cardiovascular health management for seniors in China. By 2045, the United Nations estimates that approximately 450 million individuals in China will be 60 or older. Therefore, due to the above-mentioned factors, the market will grow significantly in this region.
Based on Product Type, the market is segmented into Liquid, Softgels and Capsules. Based on Application, the market is segmented into Dietary Supplements, Animal Food & Pet Food, Functional Food & Beverages, Pharmaceuticals and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Australia, Malaysia, and Rest of Asia Pacific.
List of Key Companies Profiled
- Fuji Chemical Industries Co., Ltd.
- Aker BioMarine AS
- Nutrigold Inc.
- NWC Naturals, Inc.
- Coastside Bio Resources
- Nutracode LLC
- Schiff Nutrition International, Inc. (Reckitt Benckiser Group plc)
- Quingdao Kangjing Marine Biotechnology Co. Ltd.
- Rimfrost AS
- Norwegian Fish Oil AS
Market Report Segmentation
By Product Type- Liquid
- Softgels
- Capsules
- Dietary Supplements
- Animal Food & Pet Food
- Functional Food & Beverages
- Pharmaceuticals
- Others
- China
- Japan
- India
- South Korea
- Australia
- Malaysia
- Rest of Asia Pacific
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Asia Pacific Krill Oil Market by Product Type
Chapter 5. Asia Pacific Krill Oil Market by Application
Chapter 6. Asia Pacific Krill Oil Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Fuji Chemical Industries Co., Ltd.
- Aker BioMarine AS
- Nutrigold Inc.
- NWC Naturals, Inc.
- Coastside Bio Resources
- Nutracode LLC
- Schiff Nutrition International, Inc. (Reckitt Benckiser Group plc)
- Quingdao Kangjing Marine Biotechnology Co. Ltd.
- Rimfrost AS
- Norwegian Fish Oil AS
Methodology
LOADING...
